| __timestamp | Celldex Therapeutics, Inc. | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 10337679 |
| Thursday, January 1, 2015 | 33837000 | 18187286 |
| Friday, January 1, 2016 | 35979000 | 24758063 |
| Sunday, January 1, 2017 | 25003000 | 23666957 |
| Monday, January 1, 2018 | 19269000 | 30099855 |
| Tuesday, January 1, 2019 | 15426000 | 64947625 |
| Wednesday, January 1, 2020 | 14456000 | 186363444 |
| Friday, January 1, 2021 | 20488000 | 272611040 |
| Saturday, January 1, 2022 | 27195000 | 358782000 |
| Sunday, January 1, 2023 | 30914000 | 409864000 |
In pursuit of knowledge
In the competitive world of biotechnology, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Over the past decade, Intra-Cellular Therapies, Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting approaches. From 2014 to 2023, Intra-Cellular Therapies, Inc. increased its SG&A expenses by nearly 3,900%, peaking at over $400 million in 2023. This aggressive investment reflects their commitment to expanding market reach and operational capabilities. In contrast, Celldex Therapeutics, Inc. maintained a more conservative growth, with a 50% increase over the same period, reaching approximately $31 million in 2023. This divergence highlights differing strategic priorities: while Intra-Cellular Therapies focuses on rapid expansion, Celldex appears to prioritize steady, sustainable growth. Understanding these patterns offers valuable insights into each company's market strategy and future potential.
Cost Management Insights: SG&A Expenses for Novo Nordisk A/S and Intra-Cellular Therapies, Inc.
Novartis AG or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Pfizer Inc. and Celldex Therapeutics, Inc.
Biogen Inc. vs Intra-Cellular Therapies, Inc.: SG&A Expense Trends
BeiGene, Ltd. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Neurocrine Biosciences, Inc. vs Celldex Therapeutics, Inc.
Selling, General, and Administrative Costs: Intra-Cellular Therapies, Inc. vs Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs MiMedx Group, Inc.
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Celldex Therapeutics, Inc.
Geron Corporation or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?